Davies, Melanie J.
Chatterjee, Sudesna
Article History
First Online: 7 April 2017
Competing interests
: M.J.D. has acted as consultant, advisory board member and speaker for AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, Merck Sharp & Dohme, Novo Nordisk and Sanofi-Aventis; as an advisory board member for Servier; and as a speaker for Mitsubishi Tanabe Pharma Corporation and Takeda Pharmaceuticals International. She has received grants in support of investigator and investigator-initiated trials from Boehringer Ingelheim, Janssen, Lilly, Novo Nordisk and Sanofi-Aventis and speaker fees, educational funding or both from Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Janssen and Novo Nordisk. S.C. has received speaker fees, educational funding or both from Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Janssen and Novo Nordisk; and grants in support of investigator-initiated trials from Boehringer Ingelheim and Janssen.